Micro-Sample
Mini Sample Human INS ( Insulin ) ELISA Kit (E-MSEL-H0001)
Add to cart
For research use only.
Product Summary
| Sensitivity | 9.38 pg/mL |
| Detection Range | 15.63-1000 pg/mL |
| Sample Volume | 25 μL |
| Manual Operation Time | 1 h |
| Total Assay Time | 3 h 30 min |
| Reactivity | Human |
| Specificity | This kit recognizes INS in samples.No significant cross-reactivity or interference between INS and analogues was observed. |
| Recovery | 80%-120% |
| Sample Type | Serum, plasma and other biological fluids |
| Detection Method | Colorimetric method, ELISA, Sandwich |
| Assay Type | Sandwich-ELISA |
| Size | 96T / 48T / 24T / 96T*5 / 96T*10 |
| Storage | 2-8℃ |
| Expiration Date | 12 months |
Performance
| Typical data |
The following data was generated by the Quality Control Department, under controlled laboratory conditions (ambient temperature: 18-25 °C, relative humidity: 35-75%) using standardized procedures (TMB reaction at 37 °C in the dark for 15 minutes, followed by termination and OD measurement). These values are provided for reference only.
Actual results may vary due to differences in laboratory conditions, operator technique, and equipment. Users are required to generate a standard curve using their own experimental data.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Precision |
Intra-assay Precision (Within-run Precision): Three samples representing low, mid, and high concentrations of Human INS were tested 20 times on a single plate.
Inter-assay Precision (Between-run Precision): Three samples representing low, mid, and high concentrations of Human INS were tested on three separate plates, with 20 replicates per plate, to assess variability among assays.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recovery |
The recovery of Human INS was evaluated by spiking samples at low, mid, and high concentrations across the assay range in various sample matrices.
The assay performance was assessed by comparing the measured concentrations to the expected spiked amounts to determine the percent recovery.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Linearity |
Linearity of the assay was evaluated by spiking samples with high concentrations of Human INS and performing serial dilutions using Standard & Sample Diluent to produce concentrations spanning the assay's dynamic range.
The measured values were then compared to the expected concentrations to assess the linearity of response.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Stability |
Each kit batch is subjected to accelerated stability testing and real-time stability monitoring. Sample performance is evaluated after storage at 37 °C for 10 days to assess the impact of elevated temperature on assay reliability and reagent integrity.
|
|||||||||||||||||||||||||||||||||||||||||||||
Test Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to INS . Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for INS and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain INS , biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of INS . You can calculate the concentration of INS in the samples by comparing the OD of the samples to the standard curve.
Background
Insulin is a small polypeptide hormone of 51 amino acids composed of an A chain of 21 residues and a B chain of 30 residues held together by two interchain disulfide bonds, with a third intrachain bond within the A chain; the mature molecule has a mass of about 5.8 kDa. It is synthesized in pancreatic beta cells as preproinsulin, which is cleaved in the endoplasmic reticulum to proinsulin and then processed by the prohormone convertases PC1/3 and PC2 and by carboxypeptidase E within immature secretory granules, releasing insulin and the connecting peptide (C-peptide) in equimolar amounts. Insulin is stored in mature granules as zinc-containing hexameric crystals and released by exocytosis.
Glucose is the principal regulator of insulin secretion: it enters beta cells through GLUT2, is phosphorylated by glucokinase and oxidized to raise the ATP/ADP ratio, which closes ATP-sensitive potassium channels, depolarizes the membrane and triggers calcium influx and granule fusion. Incretins such as GLP-1 and GIP, amino acids, fatty acids and vagal signals potentiate this response, whereas sympathetic activation and somatostatin inhibit it. Insulin acts through the insulin receptor, a receptor tyrosine kinase that phosphorylates insulin receptor substrates and activates PI3K-Akt and Ras-MAPK signalling. In skeletal muscle and adipose tissue, Akt drives translocation of GLUT4 to the plasma membrane and increases glucose uptake; in the liver, insulin stimulates glycogen synthesis and lipogenesis and suppresses gluconeogenesis and glycogenolysis. Insulin also promotes protein synthesis, cell growth and survival, and it is the only hormone that lowers blood glucose.
Disorders of insulin production or action define the major forms of diabetes. Autoimmune destruction of beta cells causes type 1 diabetes, whereas type 2 diabetes results from insulin resistance combined with progressive beta-cell failure; monogenic forms include MODY and neonatal diabetes, and severe insulin resistance occurs in lipodystrophy and in insulin receptor mutations. Excessive insulin secretion, typically from a pancreatic beta-cell tumour, produces fasting hypoglycaemia with Whipple's triad, and insulin autoantibodies can cause the insulin autoimmune syndrome. Because insulin and C-peptide are co-secreted, measuring both allows assessment of beta-cell function, differentiation of endogenous from exogenous hyperinsulinaemia, calculation of insulin resistance indices such as HOMA-IR, and monitoring of insulinoma, bariatric surgery and islet graft function.
| Gene Alias | INS |
| Gene ID | 3630 |
| Uniport ID | P01308 |
| Protein Alias | INS |
| Research Area | CellBiology , Neuroscience |
-
IF:{{item.impact}}
Journal:{{item.journal}} ({{item.year}})
DOI:{{item.doi}}Reactivity:{{item.species}}
Sample Type:{{item.sample_type}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
No files available. Please enter the correct identification code in the search area to query the relevant documents.
| Title | Status | Valid until | Action | |
|---|---|---|---|---|
| {{v.文件名}} | {{v.status_str}} | {{v.timestamp_str}} | Download | / |
*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.
Resources
Contact with Us
Toll-free: 1-888-852-8623
Tel: 1-832-243-6086
Add:
14780 Memorial Drive, Suite 105, Houston, Texas, 77079, USA

